3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
5
Phase 2
4
Phase 3
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Brain Neoplasms
23
Carcinoma, Non-Small-Cell Lung
15
Neoplasm Metastasis
14
Carcinoma, Hepatocellular
11
Lung Neoplasms
10
Prostatic Neoplasms
9
Breast Neoplasms
5
Neoplasms
4
Melanoma
3
Carcinoma, Renal Cell
3
Small Cell Lung Carcinoma
2
Colorectal Neoplasms
2
Central Nervous System Neoplasms
2
Stage II Prostate Adenocarcinoma AJCC v7
1
Sarcoma, Ewing
1
Radiation Therapy
1
Radiation Injuries
1
Prostatic Neoplasms, Castration-Resistant
1
Prostate Cancer Metastatic
1
Pituitary Neoplasms
1
Patients Receiving Fractionated Stereotactic Radiotherapy
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Oligometastatic Hormone Sensitive Prostate Cancer
1
Neurotoxicity Syndromes
1
Neuroma, Acoustic
1
Nasopharyngeal Carcinoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Growth Hormone-Secreting Pituitary Adenoma
1
Interventions
Interferon-alpha
7
aldesleukin
6
Sunitinib
6
Radiotherapy
5
Nivolumab
5
Doxorubicin
5
Vincristine
4
Ipilimumab
4
Filgrastim
4
Dactinomycin
4
Chemotherapy, Adjuvant
4
Axitinib
4
cabozantinib
3
Sorafenib
3
Everolimus
3
Etoposide
3
Cyclophosphamide
3
temsirolimus
2
pembrolizumab
2
Ifosfamide
2
G250 monoclonal antibody
2
Fluorouracil
2
Carboplatin
2
Bevacizumab
2
vitespin
1
shark cartilage extract
1
pazopanib
1
lenvatinib
1
glutamic acid diethyl ester
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Kidney Neoplasms
×
Radiosurgery
×
Clear all
NCT06726421
2026-01-15
STROKER
Sun Yat-sen University
Phase 3
Recruiting
252 enrolled